BioCatalyst

RYTM — RHYTHM PHARMACEUTICALS, INC. catalysts

1 verified catalyst event(s) for RHYTHM PHARMACEUTICALS, INC. (ticker RYTM). Each is linked to its official source. Verified as of 2026-11-04.

Next verified catalyst

2027-03-13 — A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NC · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03-13
in 4mo
ESTIMATED
 READOUT
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-s
Phase 3 · Hypothalamic Obesity, Multiple Pituitary Hormone Deficiency Genetic Form
 RYTM RHYTHM PHARMACEUTICALS, INC. Setmelanotide ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.